Slideshow

FDA Drug and Biologic Approvals for Neurology: 2017 Midyear Review

Seven new drugs were approved for treatment of neurological disorders, including Parkinson disease, multiple sclerosis, and amyotrophic lateral sclerosis.

Newsletter

Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.

Related Videos
Michael Kaplitt, MD, PhD
María L. De León, MD
Molly Abbott, BM BCh
Laren Becker, MD, PhD
David Shprecher, DO, MSci, FAAN
Pamela Zeilman, NP
 Esther Labib-Kiyarash, MSHA, CPHQ
Justin Martello, MD
William Ondo, MD
© 2025 MJH Life Sciences

All rights reserved.